Literature DB >> 8241615

Drug-induced immune neutropenia.

D F Stroncek1.   

Abstract

Drug-induced immune-mediated neutropenia is a serious complication of therapy with many different drugs. Its clinical presentation and outcome are highly variable. In addition to the drugs listed in this review it is likely that many other drugs also cause immune-mediated neutropenia but drug-dependent neutrophil antibodies were not reported because of the lack of widespread availability of testing. With the exception of quinine-dependent antibodies in three patients, the neutrophil antigens recognized by the drug-dependent antibodies are not known; however, the recent development of MAIGA assays will likely help identify the antigens other drug-dependent neutrophil antibodies recognize.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241615     DOI: 10.1016/s0887-7963(93)70146-7

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN: 0887-7963


  10 in total

1.  Fine specificity of drug-dependent antibodies reactive with a restricted domain of platelet GPIIIA.

Authors:  Julie A Peterson; Tamara N Nelson; Adam J Kanack; Richard H Aster
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

Review 2.  Non-chemotherapy drug-induced neutropenia: key points to manage the challenges.

Authors:  Brian R Curtis
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 3.  Molecular nature of antigens implicated in immune neutropenias.

Authors:  Juergen Bux
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

4.  Patients with quinine-induced immune thrombocytopenia have both "drug-dependent" and "drug-specific" antibodies.

Authors:  Daniel W Bougie; Peter R Wilker; Richard H Aster
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

Review 5.  Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.

Authors:  Brian A Baldo; Nghia H Pham
Journal:  Cancer Metastasis Rev       Date:  2013-12       Impact factor: 9.264

Review 6.  [Autoimmune thrombocytopenia, neutropenia and hemolysis].

Authors:  A Greinacher; J Bux; A Salama
Journal:  Internist (Berl)       Date:  2009-03       Impact factor: 0.743

Review 7.  Idiosyncratic drug-induced haematological abnormalities. Incidence, pathogenesis, management and avoidance.

Authors:  W N Patton; S B Duffull
Journal:  Drug Saf       Date:  1994-12       Impact factor: 5.606

8.  Immune mediated neutropenia and thrombocytopenia in 3 giant schnauzers.

Authors:  Cheryl L Vargo; Susan M Taylor; Deborah M Haines
Journal:  Can Vet J       Date:  2007-11       Impact factor: 1.008

Review 9.  Adverse events to monoclonal antibodies used for cancer therapy: Focus on hypersensitivity responses.

Authors:  Brian A Baldo
Journal:  Oncoimmunology       Date:  2013-10-17       Impact factor: 8.110

10.  Immune-mediated neutropenia in 2 dogs.

Authors:  P M McManus; C Litwin; L Barber
Journal:  J Vet Intern Med       Date:  1999 Jul-Aug       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.